Unusual finding on bone scintigraphy: Cerebral 99m-tc mdp involvement
Open Access
- 2 September 2024
- journal article
- Published by Hatay Mustafa Kemal University Faculty of Medicine in Interdisciplinary Medical Journal
- Vol. 15 (52) , 96-98
Abstract
99mTc-MDP (99mTc-methylene diphosphonate) uptake in the brain parenchyma was observed in the scintigraphic imaging of a 56 years old male patient with renal cell carcinoma (RCC), who was referred to our clinic for metastasis screening due to widespread bone pain. Uptake of 99mTc-MDP in the brain parenchyma in bone scintigraphy is a rare finding. This case is presented to reveal the causes of cerebral 99mTc-MDP involvement.Keywords
This publication has 8 references indexed in Scilit:
- Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further workNuclear Medicine Communications, 2020
- The EANM practice guidelines for bone scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Altered Biodistribution of Radiopharmaceuticals Used in Bone ScintigraphySeminars in Nuclear Medicine, 2015
- Patterns, Variants, Artifacts, and Pitfalls in Conventional Radionuclide Bone Imaging and SPECT/CTSeminars in Nuclear Medicine, 2009
- Middle cerebral artery infarct demonstrated on bone scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- The Role of Single-Photon Emission Computed Tomography/Computed Tomography in Benign and Malignant Bone DiseaseSeminars in Nuclear Medicine, 2006
- Radionuclide Bone Imaging: An Illustrative ReviewRadioGraphics, 2003
- Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.RadioGraphics, 1993